UNSPSC 51381910: Parecoxib sodium
Commodity
Code facts
- Part of
-
-
51000000
-
51380000
- 51381900
-
51380000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51381910
Definition
This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H17N2O4S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EB87433V6F, chemically known as propanamide, n-((4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)-, sodium salt but more generally known as parecoxib sodium, which bears US NIH Compound Identifier 9576744. European Medicines Agency schedules Parecoxib sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12548MIG.
Read the full definition
Most nations, for tariff and trade purposes, schedule parecoxib sodium under HS 29350090 and SITC 51580. As of Q4 2014, PARECOXIB SODIUM remains US FDA's Preferred Term for this commodity. Parecoxib sodium bears US NLM identifiers UMLS ID C0915144 and NCI Concept Code C73831. SMILES: CCC(=O)[N-]S(=O)(=O)C1CCC(CC1)C2C(ONC2C3CCCCC3)C.[NA+].
About UNSPSC 51381910
UNSPSC 51381910 Parecoxib sodium is a Commodity code. The recent state and local procurement activity under this code does not align with the code's nominal pharmaceutical scope — the single recent opportunity posted by Seminole County, Florida solicits naloxone and drug deactivation systems rather than parecoxib sodium, a nonsteroidal anti-inflammatory pain medication. The mismatch suggests either a coding error in the county's procurement system or a broader, loosely curated pharmaceutical and medical-supply category that encompasses multiple active pharmaceutical ingredients and medical devices. Based on available records, the code shows limited recent activity specifically targeted at parecoxib sodium procurement by state and local governments.
Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through a competitive bidding process, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, FL 32771. The bid deadline was July 26, 2023 (a date that predates the posting by three years, indicating a data consistency issue in the source). The county required vendors to submit electronic bids through its e-Procurement Portal, include all shipping and delivery costs in their proposals, provide unit costs for each line item, and comply with drug-free workplace certification and E-Verify requirements. The contract carried a two-year initial term with an option for one-year renewal and included a three-month probationary termination clause. The procurement noted potential FEMA funding and corresponding compliance obligations under federal environmental regulations. Without additional recent opportunities under this code, assessment of geographic spread, issuing-body concentration, or market activity remains limited.
Quick answers
What is UNSPSC 51381910?
UNSPSC 51381910 is Parecoxib sodium, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51381910?
UNSPSC 51381910 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51381910
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code